CG Oncology (CGON) announced the appointment of Christina Rossi to its Board of Directors. Additionally, Simone Song, Senior Partner, ORI Capital, has resigned from the Board effective November 22, 2025.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGON:
- CG Oncology initiated with a Buy at Truist
- CG Oncology price target raised to $61 from $53 at RBC Capital
- CG Oncology, Inc.: Promising Future with Creto’s Accelerated Approval Path and Market Differentiation
- Strategic Advancements and Risk Mitigation Drive Buy Rating for CG Oncology, Inc.
- CG Oncology Advances Bladder Cancer Therapy Development